These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 35014832)
1. In Cellulo Crystallization of Human Neuraminidase 1 and Biological Roles of Tsukimoto J; Takeuchi Y; Horii Y; Iniwa T; Fukushi Y; Nishioka SI; Itoh K ACS Appl Bio Mater; 2022 Jan; 5(1):205-213. PubMed ID: 35014832 [TBL] [Abstract][Full Text] [Related]
2. Lysosomal sialidase NEU1, its intracellular properties, deficiency, and use as a therapeutic agent. Itoh K; Tsukimoto J Glycoconj J; 2023 Dec; 40(6):611-619. PubMed ID: 38147151 [TBL] [Abstract][Full Text] [Related]
3. Protective protein/cathepsin A rescues N-glycosylation defects in neuraminidase-1. Wang D; Zaitsev S; Taylor G; d'Azzo A; Bonten E Biochim Biophys Acta; 2009 Apr; 1790(4):275-82. PubMed ID: 19714866 [TBL] [Abstract][Full Text] [Related]
4. Improvement of Production and Isolation of Human Neuraminidase-1 Koiwai K; Tsukimoto J; Higashi T; Mafuné F; Miyajima K; Nakane T; Matsugaki N; Kato R; Sirigu S; Jakobi A; Wilmanns M; Sugahara M; Tanaka T; Tono K; Joti Y; Yabashi M; Nureki O; Mizohata E; Nakatsu T; Nango E; Iwata S; Chavas LMG; Senda T; Itoh K; Yumoto F ACS Appl Bio Mater; 2019 Nov; 2(11):4941-4952. PubMed ID: 35021494 [No Abstract] [Full Text] [Related]
5. Lysosomal localization of Japanese medaka (Oryzias latipes) Neu1 sialidase and its highly conserved enzymatic profiles with human. Ryuzono S; Takase R; Oishi K; Ikeda A; Chigwechokha PK; Funahashi A; Komatsu M; Miyagi T; Shiozaki K Gene; 2016 Jan; 575(2 Pt 2):513-523. PubMed ID: 26432003 [TBL] [Abstract][Full Text] [Related]
6. Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement. Oheda Y; Kotani M; Murata M; Sakuraba H; Kadota Y; Tatano Y; Kuwahara J; Itoh K Glycobiology; 2006 Apr; 16(4):271-80. PubMed ID: 16361247 [TBL] [Abstract][Full Text] [Related]
7. The sialidase NEU1 directly interacts with the juxtamembranous segment of the cytoplasmic domain of mucin-1 to inhibit downstream PI3K-Akt signaling. Hyun SW; Imamura A; Ishida H; Piepenbrink KH; Goldblum SE; Lillehoj EP J Biol Chem; 2021 Nov; 297(5):101337. PubMed ID: 34688655 [TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of Neu1-knockout zebrafish and its abnormal clinical phenotypes. Okada K; Takase R; Hamaoka Y; Honda A; Ikeda A; Hokazono Y; Maeda Y; Hayasaka O; Kotani T; Komatsu M; Shiozaki K Biochem J; 2020 Aug; 477(15):2841-2857. PubMed ID: 32686823 [TBL] [Abstract][Full Text] [Related]
9. Modulation of TLR4 Sialylation Mediated by a Sialidase Neu1 and Impairment of Its Signaling in Karmakar J; Roy S; Mandal C Front Immunol; 2019; 10():2360. PubMed ID: 31649671 [TBL] [Abstract][Full Text] [Related]
10. Structure of the immunoregulatory sialidase NEU1. Gorelik A; Illes K; Mazhab-Jafari MT; Nagar B Sci Adv; 2023 May; 9(20):eadf8169. PubMed ID: 37205763 [TBL] [Abstract][Full Text] [Related]
11. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo. Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251 [TBL] [Abstract][Full Text] [Related]
12. Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization. Bonten EJ; Campos Y; Zaitsev V; Nourse A; Waddell B; Lewis W; Taylor G; d'Azzo A J Biol Chem; 2009 Oct; 284(41):28430-28441. PubMed ID: 19666471 [TBL] [Abstract][Full Text] [Related]
13. Neu1 deficiency increases the susceptibility of zebrafish to Edwardsiella piscicida infection via lysosomal dysfunction. Sahashi D; Kubo Y; Ishii M; Ikeda A; Yamasaki C; Komatsu M; Shiozaki K Gene; 2022 Aug; 836():146667. PubMed ID: 35714800 [TBL] [Abstract][Full Text] [Related]
14. [Orientation of three lysosomal enzymes in the mouse inner ear and hearing loss in enzyme gene deficiency]. Guo YK; Xie DH; Yang XM Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):79-84. PubMed ID: 16562682 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages. Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103 [TBL] [Abstract][Full Text] [Related]
17. New Insights into Molecular Organization of Human Neuraminidase-1: Transmembrane Topology and Dimerization Ability. Maurice P; Baud S; Bocharova OV; Bocharov EV; Kuznetsov AS; Kawecki C; Bocquet O; Romier B; Gorisse L; Ghirardi M; Duca L; Blaise S; Martiny L; Dauchez M; Efremov RG; Debelle L Sci Rep; 2016 Dec; 6():38363. PubMed ID: 27917893 [TBL] [Abstract][Full Text] [Related]
18. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency. Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849 [TBL] [Abstract][Full Text] [Related]
19. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Seyrantepe V; Hinek A; Peng J; Fedjaev M; Ernest S; Kadota Y; Canuel M; Itoh K; Morales CR; Lavoie J; Tremblay J; Pshezhetsky AV Circulation; 2008 Apr; 117(15):1973-81. PubMed ID: 18391110 [TBL] [Abstract][Full Text] [Related]
20. Short-term, high dose enzyme replacement therapy in sialidosis mice. Wang D; Bonten EJ; Yogalingam G; Mann L; d'Azzo A Mol Genet Metab; 2005 Jul; 85(3):181-9. PubMed ID: 15979029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]